Abstract

Mediterranean diet can be considered the paradigm of a healthy dietary pattern by virtue of its food components. Red wine is one of such components particularly rich in bioactive phytochemicals as polyphenols. The cardioprotective potential of light-to-moderate, regular red wine consumption at main meals has been advocated by a number of epidemiological observational studies. However, although preclinical in vitro/in vivo studies demonstrated the vasodilatory, antiplatelet, antioxidant, and antiinflammatory properties of red wine and polyphenols, the number of randomized clinical trials (RCTs) is still scanty to substantiate these observations and a cause-effect relation. Therefore there is not sufficient high-quality evidence to recommend that individuals initiate alcohol consumption for cardiovascular benefit, whereas, for those already drinking, consumption should be limited to recommended amounts at main meals.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.